Suscribirse

IMAGING APPROACH TO STAGING OF RENAL CELL CARCINOMA - 11/09/11

Doi : 10.1016/S0094-0143(05)70399-2 
Robert E. Bechtold, MD *, Ronald J. Zagoria, MD *

Resumen

Contemporary imaging techniques have contributed significantly to the detection and staging of renal cell carcinoma. The accuracy of current imaging methods in detecting renal cell carcinoma approaches 100%.59 Almost as many new renal cell carcinomas are being detected incidentally as are being found in patients investigated because of hematuria or flank pain.36 The initial detection of renal masses can be achieved by many imaging methods, including excretory urography,10 ultrasound (US), or CT scan. Once found, however, the main objective is to determine the pathologic nature and stage of a renal mass.10

Survival with renal cell carcinoma depends on the local extent of the primary tumor, presence or absence of distant metastases,41 and tumor histology. The stage at the time of the initiation of treatment correlates directly with prognosis.2 In patients with well-defined tumors with no evidence of capsular, vascular, or lymph node involvement, survival depends on tumor size and grade.4 Evidence shows that CT scan findings can suggest the histologic grade4 in some cases. Radiotherapy and chemotherapy have little effect on renal cell carcinoma,11 making surgery the only effective treatment. Surgical planning largely depends on preoperative imaging delineation of disease extent. Therefore, establishing an accurate stage of the tumor at the earliest possible opportunity is important for properly managing the primary neoplasm and providing accurate prognostic information for the patient. The best overall imaging approach should determine stage and extent of disease accurately, especially identifying distant metastases and adjacent organ invasion, either of which indicates incurable disease.

Many different staging systems have been developed by different authorities. The first staging system for renal cell carcinoma was developed by Flocks and Kadesky in 1958, which subsequently was modified by Robson and associates in 1963,43 and this remains one of the primary staging systems in use today (Table 1). The TNM classification proposed by the American Joint Committee for Cancer Staging and End Results Reporting has not gained wide acceptance, possibly because of the greater number of subgroups involved,41 and the Robson staging system is used in the imaging literature to standardize staging accuracy rates.

Many imaging techniques are available to help stage renal cell carcinoma, including CT scan, MR imaging, US, renal angiography (RA), digital subtraction angiography (DSA), and inferior venacavography (IVCG). The choice of which to use often depends on local physician preferences, patient risk factors, the strengths of each of these imaging methods, and the stage of a tumor in question.

This article describes the features of each of these imaging methods in relation to staging renal cell carcinoma. The discussion centers on advantages, limitations, technical aspects, typical findings, accuracy rates at each stage and overall, and pitfalls associated with each method. The greatest attention is given to CT scan and MR imaging because they are the primary imaging methods with which current staging is accomplished. Finally, the authors conclude with a suggested overall approach to staging renal cell carcinoma, incorporating all methods in a proper order.

El texto completo de este artículo está disponible en PDF.

Esquema


 Address reprint requests to Robert E. Bechtold, MD Department of Radiology Bowman Gray School of Medicine of Wake Forest University Medical Center Boulevard Winston-Salem, NC 27157–1088


© 1997  W. B. Saunders Company. Publicado por Elsevier Masson SAS. Todos los derechos reservados.© 1995  © 1995 
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 24 - N° 3

P. 507-522 - août 1997 Regresar al número
Artículo precedente Artículo precedente
  • RADIOLOGIC EVALUATION OF SMALL AND INDETERMINANT RENAL MASSES
  • Nancy S. Curry, Nabil K. Bissada
| Artículo siguiente Artículo siguiente
  • CURRENT CONCEPTS AND CONTROVERSIES IN IMAGING OF RENAL CYSTIC DISEASES
  • Errol Levine, David S. Hartman, Jon W. Meilstrup, Mark A. Van Slyke, Kenneth A. Edgar, Julie C. Barth

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.